KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLiabilities from Discontinued OperationsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neogenomics (NEO) Current Leases (2016 - 2026)

Neogenomics filings provide 17 years of Current Leases readings, the most recent being $4.8 million for Q1 2026.

  • On a quarterly basis, Current Leases rose 57.01% to $4.8 million in Q1 2026 year-over-year; TTM through Mar 2026 was $4.8 million, a 57.01% increase, with the full-year FY2025 number at $4.8 million, up 41.26% from a year prior.
  • Current Leases hit $4.8 million in Q1 2026 for Neogenomics, up from $4.8 million in the prior quarter.
  • In the past five years, Current Leases ranged from a high of $7.4 million in Q2 2023 to a low of $4000.0 in Q3 2023.
  • Median Current Leases over the past 5 years was $4.1 million (2025), compared with a mean of $3.7 million.
  • Biggest five-year swings in Current Leases: crashed 98.31% in 2022 and later surged 92800.0% in 2024.
  • Neogenomics' Current Leases stood at $70000.0 in 2022, then surged by 7914.29% to $5.6 million in 2023, then plummeted by 39.73% to $3.4 million in 2024, then skyrocketed by 41.26% to $4.8 million in 2025, then rose by 1.09% to $4.8 million in 2026.
  • The last three reported values for Current Leases were $4.8 million (Q1 2026), $4.8 million (Q4 2025), and $4.5 million (Q3 2025) per Business Quant data.